G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 31,900
-1,100 (-3.33%)
At close: Sep 18, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 527.8 billion as of September 18, 2026. Its market cap has decreased by -53.60% in one year.
Market Cap
527.80B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
31,900.00
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 527.80B, an increase of 4.87%. That is a compound annual growth rate of 4.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 527.80B | -52.03% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 314.66B |
| HEM Pharma | 244.39B |
| DAE HWA Pharmaceutical | 210.94B |
| Vivozon Pharmaceutical | 176.58B |
| NOVAREX | 174.95B |
| CellBion | 173.83B |
| GC WellBeing | 168.07B |
| Cosmax Nbt | 152.72B |